Search Results

Linifanib (ABT-869) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Linifanib (ABT-869) is a structurally novel, potent inhibitor of RTK, VEGF and PDGF with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGFR-??, KDR, and CSF-1R, respectively.

More Information Supplier Page

Linifanib (ABT-869) 5mg 5mg  | Purity Not Available

Adooq Bioscience

Linifanib (ABT-869) is a structurally novel, potent inhibitor of RTK, VEGF and PDGF with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGFR-??, KDR, and CSF-1R, respectively.

More Information Supplier Page

Linifanib (ABT-869) 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Linifanib (ABT-869) is a structurally novel, potent inhibitor of RTK, VEGF and PDGF with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGFR-??, KDR, and CSF-1R, respectively.

More Information Supplier Page

Linifanib (ABT-869) 100mg 100mg  | Purity Not Available

Adooq Bioscience

Linifanib (ABT-869) is a structurally novel, potent inhibitor of RTK, VEGF and PDGF with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGFR-??, KDR, and CSF-1R, respectively.

More Information Supplier Page

Linifanib (ABT-869) 10mg 10mg  | Purity Not Available

Adooq Bioscience

Linifanib (ABT-869) is a structurally novel, potent inhibitor of RTK, VEGF and PDGF with IC50 of 0.2, 2, 4, and 7 nM for human endothelial cells, PDGFR-??, KDR, and CSF-1R, respectively.

More Information Supplier Page

ABT-751 50mg 50mg  | Purity Not Available

Adooq Bioscience

ABT-751 is an antimitotic agent, inhibits microtubule polymerization, binds to β-tubulin on the colchine site; blocks cell cycle at G2M phase and induces apoptosis.

More Information Supplier Page